Experience in Biotechnology Business Strategy, Due Diligence, Market Research, Quantitative and Qualitative Data Analysis, Valuation, Financial Modeling. Therapy areas: Gene Editing (CRISPR, TALEN, ZFN), Gene Therapy (AAV), Type II Diabetes, RNA-based therapies, Biosimilars, Rare Diseases (Orphan Drugs), Neuro-degenerative diseases
Director - Life Sciences Research at General Atlantic